

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cornea development in camera-type eye (GO:0061303) | 9.31378600 |
| 2 | astrocyte differentiation (GO:0048708) | 7.22038837 |
| 3 | regulation of timing of cell differentiation (GO:0048505) | 6.33665453 |
| 4 | regulation of development, heterochronic (GO:0040034) | 6.20919405 |
| 5 | synaptic vesicle endocytosis (GO:0048488) | 5.72338448 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.53399261 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.37217078 |
| 8 | gland morphogenesis (GO:0022612) | 4.98124700 |
| 9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.61798973 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.54547120 |
| 11 | synaptic vesicle maturation (GO:0016188) | 4.45574455 |
| 12 | regulation of synaptic vesicle transport (GO:1902803) | 4.42756068 |
| 13 | hindbrain development (GO:0030902) | 4.39900772 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.38284559 |
| 15 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 4.34003052 |
| 16 | locomotory exploration behavior (GO:0035641) | 4.30030347 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.25324292 |
| 18 | regulation of transcription involved in cell fate commitment (GO:0060850) | 4.24359851 |
| 19 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.20792629 |
| 20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.18200633 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.13422968 |
| 22 | positive regulation of cell fate commitment (GO:0010455) | 4.07031563 |
| 23 | embryonic camera-type eye morphogenesis (GO:0048596) | 4.06958179 |
| 24 | positive regulation of neuroblast proliferation (GO:0002052) | 4.05891615 |
| 25 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.05313775 |
| 26 | vocalization behavior (GO:0071625) | 4.00615669 |
| 27 | regulation of synapse structural plasticity (GO:0051823) | 3.95913393 |
| 28 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.95891505 |
| 29 | protein localization to synapse (GO:0035418) | 3.95546019 |
| 30 | establishment of protein localization to Golgi (GO:0072600) | 3.93077392 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 3.91105818 |
| 32 | intraciliary transport (GO:0042073) | 3.90657513 |
| 33 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.90357451 |
| 34 | glutamate secretion (GO:0014047) | 3.87088382 |
| 35 | protein targeting to Golgi (GO:0000042) | 3.86569914 |
| 36 | regulation of cilium movement (GO:0003352) | 3.83138535 |
| 37 | glandular epithelial cell development (GO:0002068) | 3.82190063 |
| 38 | neurotransmitter secretion (GO:0007269) | 3.80289221 |
| 39 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.78547999 |
| 40 | histone H3-K9 methylation (GO:0051567) | 3.74119399 |
| 41 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.73029817 |
| 42 | cilium morphogenesis (GO:0060271) | 3.71756813 |
| 43 | regulation of hexokinase activity (GO:1903299) | 3.64933360 |
| 44 | regulation of glucokinase activity (GO:0033131) | 3.64933360 |
| 45 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.63509555 |
| 46 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.63509555 |
| 47 | photoreceptor cell development (GO:0042461) | 3.62376713 |
| 48 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.60685521 |
| 49 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.58575925 |
| 50 | neuron cell-cell adhesion (GO:0007158) | 3.58517019 |
| 51 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.57366186 |
| 52 | glutamate receptor signaling pathway (GO:0007215) | 3.56830371 |
| 53 | response to pheromone (GO:0019236) | 3.55289699 |
| 54 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.52999457 |
| 55 | microtubule nucleation (GO:0007020) | 3.50936074 |
| 56 | neuron-neuron synaptic transmission (GO:0007270) | 3.49812542 |
| 57 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.49317924 |
| 58 | N-glycan processing (GO:0006491) | 3.45973629 |
| 59 | exploration behavior (GO:0035640) | 3.40871490 |
| 60 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.36687536 |
| 61 | cellular potassium ion homeostasis (GO:0030007) | 3.36207025 |
| 62 | peptidyl-lysine trimethylation (GO:0018023) | 3.35596069 |
| 63 | eye photoreceptor cell development (GO:0042462) | 3.34807824 |
| 64 | histone H3-K9 modification (GO:0061647) | 3.33146886 |
| 65 | activation of protein kinase A activity (GO:0034199) | 3.32726266 |
| 66 | neuron fate commitment (GO:0048663) | 3.27335598 |
| 67 | neuron recognition (GO:0008038) | 3.27326307 |
| 68 | protein localization to Golgi apparatus (GO:0034067) | 3.25206392 |
| 69 | protein polyglutamylation (GO:0018095) | 3.24867531 |
| 70 | positive regulation of synapse maturation (GO:0090129) | 3.24339423 |
| 71 | receptor catabolic process (GO:0032801) | 3.24203476 |
| 72 | membrane depolarization during action potential (GO:0086010) | 3.23353731 |
| 73 | layer formation in cerebral cortex (GO:0021819) | 3.21676024 |
| 74 | neuronal action potential propagation (GO:0019227) | 3.20413841 |
| 75 | neural tube formation (GO:0001841) | 3.20022092 |
| 76 | neurotransmitter transport (GO:0006836) | 3.18362648 |
| 77 | cardiac ventricle formation (GO:0003211) | 3.13591687 |
| 78 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.11610677 |
| 79 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.11220251 |
| 80 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.11220251 |
| 81 | histone H2A monoubiquitination (GO:0035518) | 3.10854094 |
| 82 | positive regulation of actin filament depolymerization (GO:0030836) | 3.10699227 |
| 83 | pyrimidine dimer repair (GO:0006290) | 3.09436136 |
| 84 | synaptic vesicle transport (GO:0048489) | 3.09130809 |
| 85 | establishment of synaptic vesicle localization (GO:0097480) | 3.09130809 |
| 86 | dorsal/ventral axis specification (GO:0009950) | 3.07968099 |
| 87 | epithelial cilium movement (GO:0003351) | 3.07154832 |
| 88 | long-term synaptic potentiation (GO:0060291) | 3.06861983 |
| 89 | regulation of neurotransmitter secretion (GO:0046928) | 3.06853491 |
| 90 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.06252612 |
| 91 | histone H2A acetylation (GO:0043968) | 3.06081263 |
| 92 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.03473976 |
| 93 | long-term memory (GO:0007616) | 3.02352415 |
| 94 | artery development (GO:0060840) | 3.01889870 |
| 95 | regulation of postsynaptic membrane potential (GO:0060078) | 3.01536997 |
| 96 | macroautophagy (GO:0016236) | 3.00288916 |
| 97 | cilium movement (GO:0003341) | 3.00049348 |
| 98 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.98217246 |
| 99 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.98175357 |
| 100 | postsynaptic membrane organization (GO:0001941) | 2.96450761 |
| 101 | membrane hyperpolarization (GO:0060081) | 2.96412862 |
| 102 | regulation of synapse maturation (GO:0090128) | 2.95621985 |
| 103 | proline transport (GO:0015824) | 2.94370637 |
| 104 | glandular epithelial cell differentiation (GO:0002067) | 2.94066300 |
| 105 | regulation of neurotransmitter levels (GO:0001505) | 2.93907860 |
| 106 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.93331339 |
| 107 | regulation of synaptic plasticity (GO:0048167) | 2.92463786 |
| 108 | transmission of nerve impulse (GO:0019226) | 2.91576257 |
| 109 | cardiac chamber formation (GO:0003207) | 2.90491037 |
| 110 | negative regulation of glial cell proliferation (GO:0060253) | 2.90322953 |
| 111 | behavioral fear response (GO:0001662) | 2.90132710 |
| 112 | behavioral defense response (GO:0002209) | 2.90132710 |
| 113 | dendrite morphogenesis (GO:0048813) | 2.89003176 |
| 114 | glycosphingolipid biosynthetic process (GO:0006688) | 2.88851292 |
| 115 | ventricular system development (GO:0021591) | 2.87764510 |
| 116 | gastrulation with mouth forming second (GO:0001702) | 2.87497607 |
| 117 | positive regulation of defense response to virus by host (GO:0002230) | 2.86602210 |
| 118 | membrane depolarization (GO:0051899) | 2.85406298 |
| 119 | axonal fasciculation (GO:0007413) | 2.84837927 |
| 120 | positive regulation of membrane potential (GO:0045838) | 2.84804621 |
| 121 | axoneme assembly (GO:0035082) | 2.83733596 |
| 122 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.83409375 |
| 123 | RNA destabilization (GO:0050779) | 2.82075662 |
| 124 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.81048644 |
| 125 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.81000529 |
| 126 | protein localization to cilium (GO:0061512) | 2.79990253 |
| 127 | regulation of synaptic transmission (GO:0050804) | 2.79663835 |
| 128 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.79532180 |
| 129 | glial cell proliferation (GO:0014009) | 2.79529562 |
| 130 | regulation of neurotransmitter transport (GO:0051588) | 2.78696589 |
| 131 | histone H2A ubiquitination (GO:0033522) | 2.78157586 |
| 132 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.78075917 |
| 133 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.77963375 |
| 134 | nucleobase catabolic process (GO:0046113) | 2.77360034 |
| 135 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.77124936 |
| 136 | positive regulation of synaptic transmission (GO:0050806) | 2.75969582 |
| 137 | dendritic spine morphogenesis (GO:0060997) | 2.74073427 |
| 138 | gamma-aminobutyric acid transport (GO:0015812) | 2.74024246 |
| 139 | fear response (GO:0042596) | 2.73870712 |
| 140 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.73408982 |
| 141 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.73172259 |
| 142 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.72019221 |
| 143 | nonmotile primary cilium assembly (GO:0035058) | 2.70987353 |
| 144 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.70094341 |
| 145 | mitochondrion degradation (GO:0000422) | 2.68879515 |
| 146 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.68506362 |
| 147 | smoothened signaling pathway (GO:0007224) | 2.68475867 |
| 148 | establishment of vesicle localization (GO:0051650) | 2.68311747 |
| 149 | cerebellar granule cell differentiation (GO:0021707) | 2.67080548 |
| 150 | response to auditory stimulus (GO:0010996) | 2.66826467 |
| 151 | dosage compensation (GO:0007549) | 2.66237400 |
| 152 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.65916992 |
| 153 | regulation of neuroblast proliferation (GO:1902692) | 2.63495759 |
| 154 | pituitary gland development (GO:0021983) | 2.62678902 |
| 155 | innervation (GO:0060384) | 2.61854550 |
| 156 | response to histamine (GO:0034776) | 2.61511264 |
| 157 | cell communication by electrical coupling (GO:0010644) | 2.61247699 |
| 158 | presynaptic membrane assembly (GO:0097105) | 2.60380570 |
| 159 | positive regulation of neural precursor cell proliferation (GO:2000179) | 2.58033336 |
| 160 | axonemal dynein complex assembly (GO:0070286) | 2.57769366 |
| 161 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.56820332 |
| 162 | sodium ion export (GO:0071436) | 2.55678781 |
| 163 | learning (GO:0007612) | 2.55207850 |
| 164 | inositol phosphate catabolic process (GO:0071545) | 2.55197148 |
| 165 | neutrophil mediated immunity (GO:0002446) | 2.54675825 |
| 166 | neuromuscular process controlling balance (GO:0050885) | 2.53913239 |
| 167 | vesicle transport along microtubule (GO:0047496) | 2.53876008 |
| 168 | organelle transport along microtubule (GO:0072384) | 2.53494754 |
| 169 | startle response (GO:0001964) | 2.53476537 |
| 170 | synapse assembly (GO:0007416) | 2.52357232 |
| 171 | myelin assembly (GO:0032288) | 2.51860144 |
| 172 | histone mRNA catabolic process (GO:0071044) | 2.50365186 |
| 173 | positive regulation of mitochondrial fission (GO:0090141) | 2.50123195 |
| 174 | embryonic eye morphogenesis (GO:0048048) | 2.48358912 |
| 175 | activated T cell proliferation (GO:0050798) | 2.47868011 |
| 176 | auditory behavior (GO:0031223) | 2.46396605 |
| 177 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.44733018 |
| 178 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.44733018 |
| 179 | RNA localization (GO:0006403) | 2.42808165 |
| 180 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.42113316 |
| 181 | negative thymic T cell selection (GO:0045060) | 2.38942688 |
| 182 | regulation of microtubule-based movement (GO:0060632) | 2.37742327 |
| 183 | lens development in camera-type eye (GO:0002088) | 2.36936147 |
| 184 | regulation of protein kinase A signaling (GO:0010738) | 2.34852736 |
| 185 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.33599166 |
| 186 | limb bud formation (GO:0060174) | 2.33036382 |
| 187 | negative regulation of granulocyte differentiation (GO:0030853) | 2.32851934 |
| 188 | microtubule-based transport (GO:0010970) | 2.32499629 |
| 189 | peptidyl-lysine methylation (GO:0018022) | 2.31901033 |
| 190 | positive regulation of TOR signaling (GO:0032008) | 2.31877905 |
| 191 | regulation of granulocyte differentiation (GO:0030852) | 2.28646328 |
| 192 | Golgi to endosome transport (GO:0006895) | 2.27623965 |
| 193 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.26121721 |
| 194 | positive regulation of granulocyte differentiation (GO:0030854) | 2.25748264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.00710054 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.61792066 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.79137288 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.75887442 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.54845823 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.49816303 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.43486155 |
| 8 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.38947991 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.37295862 |
| 10 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35448385 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.35244350 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.34777740 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.34168378 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.33368468 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.31794479 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.21327189 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.21327189 |
| 18 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.20588634 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13529936 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.12107970 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.10831414 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.06002000 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.97168015 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94355119 |
| 25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.93244503 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.90856991 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88404519 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.86502926 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.84600006 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.78552727 |
| 31 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.77208702 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.74364238 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71088757 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68569176 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64414945 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.62667851 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62525881 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.61053848 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.60921467 |
| 40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60714413 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60180087 |
| 42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.57808488 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56184347 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.52944369 |
| 45 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52229208 |
| 46 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.50471770 |
| 47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.49128134 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47338684 |
| 49 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40802857 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39238716 |
| 51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39221554 |
| 52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38271216 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37013455 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36240627 |
| 55 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.35117991 |
| 56 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.33382730 |
| 57 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.32456548 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31996370 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31124409 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29688664 |
| 61 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29133088 |
| 62 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29119542 |
| 63 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.29066099 |
| 64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.28004392 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27639123 |
| 66 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27621484 |
| 67 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.27521036 |
| 68 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26723396 |
| 69 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.26361754 |
| 70 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25978280 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25543338 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23218787 |
| 73 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22742751 |
| 74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.22164906 |
| 75 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.21332441 |
| 76 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19765002 |
| 77 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.18306424 |
| 78 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.18124723 |
| 79 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17300033 |
| 80 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17011232 |
| 81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15689349 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15470550 |
| 83 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14683336 |
| 84 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14108428 |
| 85 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13267117 |
| 86 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12905002 |
| 87 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12828789 |
| 88 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12067673 |
| 89 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11668077 |
| 90 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11325182 |
| 91 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11048203 |
| 92 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10441784 |
| 93 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.08557329 |
| 94 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.08467340 |
| 95 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.08183995 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.08115558 |
| 97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08105663 |
| 98 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07547262 |
| 99 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07510169 |
| 100 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.07213264 |
| 101 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07151365 |
| 102 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06989281 |
| 103 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06479364 |
| 104 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04812985 |
| 105 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.03267188 |
| 106 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03051264 |
| 107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02252975 |
| 108 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01836132 |
| 109 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01831478 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01346485 |
| 111 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00283831 |
| 112 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00105325 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99960265 |
| 114 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99706925 |
| 115 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.99294964 |
| 116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97742162 |
| 117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97493083 |
| 118 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97354891 |
| 119 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97354891 |
| 120 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97180998 |
| 121 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96862007 |
| 122 | TBL1_22424771_ChIP-Seq_293T_Human | 0.96154971 |
| 123 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95245100 |
| 124 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.94387182 |
| 125 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.93958873 |
| 126 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93933507 |
| 127 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.93322687 |
| 128 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93315331 |
| 129 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93183823 |
| 130 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.92379524 |
| 131 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.92237091 |
| 132 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.91998423 |
| 133 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.91960937 |
| 134 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.91460509 |
| 135 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90494048 |
| 136 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90358165 |
| 137 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89859270 |
| 138 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88689000 |
| 139 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.88689000 |
| 140 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87674869 |
| 141 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87337051 |
| 142 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.87105181 |
| 143 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86384741 |
| 144 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83462651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005257_abnormal_intraocular_pressure | 6.68995088 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.15056317 |
| 3 | MP0003880_abnormal_central_pattern | 4.04424786 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.73188760 |
| 5 | MP0008877_abnormal_DNA_methylation | 3.48114111 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.12589403 |
| 7 | MP0009745_abnormal_behavioral_response | 2.90614326 |
| 8 | MP0002102_abnormal_ear_morphology | 2.89784150 |
| 9 | MP0002064_seizures | 2.86727128 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.82021135 |
| 11 | MP0004270_analgesia | 2.81357361 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.75292598 |
| 13 | MP0002822_catalepsy | 2.58056569 |
| 14 | MP0001984_abnormal_olfaction | 2.40458403 |
| 15 | MP0002272_abnormal_nervous_system | 2.36898836 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.34702617 |
| 17 | MP0009046_muscle_twitch | 2.32779527 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.29145668 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.28289676 |
| 20 | MP0000613_abnormal_salivary_gland | 2.28104638 |
| 21 | MP0002736_abnormal_nociception_after | 2.27375441 |
| 22 | MP0001486_abnormal_startle_reflex | 2.26784081 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.20669125 |
| 24 | MP0002909_abnormal_adrenal_gland | 2.20092055 |
| 25 | MP0003183_abnormal_peptide_metabolism | 2.19079956 |
| 26 | MP0004885_abnormal_endolymph | 2.10010190 |
| 27 | MP0003121_genomic_imprinting | 2.08429560 |
| 28 | MP0002938_white_spotting | 2.05533739 |
| 29 | MP0006276_abnormal_autonomic_nervous | 2.05353179 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.93677139 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.91924111 |
| 32 | MP0004924_abnormal_behavior | 1.91924111 |
| 33 | MP0003122_maternal_imprinting | 1.89334820 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.87180891 |
| 35 | MP0002557_abnormal_social/conspecific_i | 1.85298617 |
| 36 | MP0002653_abnormal_ependyma_morphology | 1.79359446 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.77115445 |
| 38 | MP0001970_abnormal_pain_threshold | 1.74728153 |
| 39 | MP0000778_abnormal_nervous_system | 1.74511968 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.74408810 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.72599214 |
| 42 | MP0008569_lethality_at_weaning | 1.69896835 |
| 43 | MP0001440_abnormal_grooming_behavior | 1.67650467 |
| 44 | MP0005253_abnormal_eye_physiology | 1.65099229 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.64088447 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.58172969 |
| 47 | MP0003329_amyloid_beta_deposits | 1.58106929 |
| 48 | MP0002184_abnormal_innervation | 1.54223388 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.51876575 |
| 50 | MP0003633_abnormal_nervous_system | 1.51253146 |
| 51 | MP0004858_abnormal_nervous_system | 1.47061113 |
| 52 | MP0003787_abnormal_imprinting | 1.34395597 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.31693448 |
| 54 | MP0005248_abnormal_Harderian_gland | 1.30655203 |
| 55 | MP0002066_abnormal_motor_capabilities/c | 1.29404350 |
| 56 | MP0002177_abnormal_outer_ear | 1.29157643 |
| 57 | MP0003879_abnormal_hair_cell | 1.27088836 |
| 58 | MP0001986_abnormal_taste_sensitivity | 1.26688903 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.26509893 |
| 60 | MP0002234_abnormal_pharynx_morphology | 1.25805498 |
| 61 | MP0003252_abnormal_bile_duct | 1.24919991 |
| 62 | MP0000955_abnormal_spinal_cord | 1.23803157 |
| 63 | MP0002882_abnormal_neuron_morphology | 1.23187858 |
| 64 | MP0001324_abnormal_eye_pigmentation | 1.23018535 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.22920168 |
| 66 | MP0001270_distended_abdomen | 1.21260455 |
| 67 | MP0005394_taste/olfaction_phenotype | 1.21230211 |
| 68 | MP0005499_abnormal_olfactory_system | 1.21230211 |
| 69 | MP0006292_abnormal_olfactory_placode | 1.19507773 |
| 70 | MP0001177_atelectasis | 1.13256629 |
| 71 | MP0010386_abnormal_urinary_bladder | 1.10934152 |
| 72 | MP0001529_abnormal_vocalization | 1.09782394 |
| 73 | MP0003631_nervous_system_phenotype | 1.09036935 |
| 74 | MP0005551_abnormal_eye_electrophysiolog | 1.08873028 |
| 75 | MP0008874_decreased_physiological_sensi | 1.08684970 |
| 76 | MP0004142_abnormal_muscle_tone | 1.08333740 |
| 77 | MP0005391_vision/eye_phenotype | 1.08026363 |
| 78 | MP0000516_abnormal_urinary_system | 1.07951738 |
| 79 | MP0005367_renal/urinary_system_phenotyp | 1.07951738 |
| 80 | MP0000015_abnormal_ear_pigmentation | 1.04783116 |
| 81 | MP0000631_abnormal_neuroendocrine_gland | 1.02525189 |
| 82 | MP0002928_abnormal_bile_duct | 1.02040843 |
| 83 | MP0002160_abnormal_reproductive_system | 0.99423314 |
| 84 | MP0002069_abnormal_eating/drinking_beha | 0.97306891 |
| 85 | MP0000569_abnormal_digit_pigmentation | 0.95517365 |
| 86 | MP0002152_abnormal_brain_morphology | 0.94807294 |
| 87 | MP0008872_abnormal_physiological_respon | 0.94499540 |
| 88 | MP0004043_abnormal_pH_regulation | 0.93675873 |
| 89 | MP0003724_increased_susceptibility_to | 0.90644092 |
| 90 | MP0003634_abnormal_glial_cell | 0.90410976 |
| 91 | MP0000538_abnormal_urinary_bladder | 0.89327535 |
| 92 | MP0002229_neurodegeneration | 0.88325104 |
| 93 | MP0000049_abnormal_middle_ear | 0.87918178 |
| 94 | MP0006054_spinal_hemorrhage | 0.87662480 |
| 95 | MP0002090_abnormal_vision | 0.86937498 |
| 96 | MP0000751_myopathy | 0.86911110 |
| 97 | MP0001905_abnormal_dopamine_level | 0.85823603 |
| 98 | MP0005535_abnormal_body_temperature | 0.84937750 |
| 99 | MP0008260_abnormal_autophagy | 0.84535827 |
| 100 | MP0000604_amyloidosis | 0.83856297 |
| 101 | MP0000428_abnormal_craniofacial_morphol | 0.83223632 |
| 102 | MP0001919_abnormal_reproductive_system | 0.81225736 |
| 103 | MP0008961_abnormal_basal_metabolism | 0.80674498 |
| 104 | MP0004742_abnormal_vestibular_system | 0.80215457 |
| 105 | MP0005075_abnormal_melanosome_morpholog | 0.79441664 |
| 106 | MP0003172_abnormal_lysosome_physiology | 0.79003094 |
| 107 | MP0003755_abnormal_palate_morphology | 0.78765347 |
| 108 | MP0004085_abnormal_heartbeat | 0.78504371 |
| 109 | MP0003690_abnormal_glial_cell | 0.73961228 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.73732822 |
| 111 | MP0004147_increased_porphyrin_level | 0.73198983 |
| 112 | MP0000678_abnormal_parathyroid_gland | 0.72487297 |
| 113 | MP0008789_abnormal_olfactory_epithelium | 0.71908240 |
| 114 | MP0002638_abnormal_pupillary_reflex | 0.71069939 |
| 115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70217205 |
| 116 | MP0000920_abnormal_myelination | 0.69548321 |
| 117 | MP0002751_abnormal_autonomic_nervous | 0.69355123 |
| 118 | MP0006072_abnormal_retinal_apoptosis | 0.69192118 |
| 119 | MP0004133_heterotaxia | 0.68418427 |
| 120 | MP0001188_hyperpigmentation | 0.68268775 |
| 121 | MP0005389_reproductive_system_phenotype | 0.68169914 |
| 122 | MP0001963_abnormal_hearing_physiology | 0.67435463 |
| 123 | MP0002095_abnormal_skin_pigmentation | 0.67340369 |
| 124 | MP0004145_abnormal_muscle_electrophysio | 0.66207811 |
| 125 | MP0005084_abnormal_gallbladder_morpholo | 0.65542415 |
| 126 | MP0001664_abnormal_digestion | 0.65348472 |
| 127 | MP0002233_abnormal_nose_morphology | 0.64831290 |
| 128 | MP0005197_abnormal_uvea_morphology | 0.63317525 |
| 129 | MP0000681_abnormal_thyroid_gland | 0.63088906 |
| 130 | MP0003283_abnormal_digestive_organ | 0.62893007 |
| 131 | MP0003075_altered_response_to | 0.62214802 |
| 132 | MP0004484_altered_response_of | 0.61863864 |
| 133 | MP0002752_abnormal_somatic_nervous | 0.61831905 |
| 134 | MP0005410_abnormal_fertilization | 0.61251299 |
| 135 | MP0003935_abnormal_craniofacial_develop | 0.60976571 |
| 136 | MP0001943_abnormal_respiration | 0.60707980 |
| 137 | MP0010368_abnormal_lymphatic_system | 0.60587507 |
| 138 | MP0002078_abnormal_glucose_homeostasis | 0.60546285 |
| 139 | MP0005187_abnormal_penis_morphology | 0.59213493 |
| 140 | MP0005195_abnormal_posterior_eye | 0.59056559 |
| 141 | MP0003385_abnormal_body_wall | 0.56340181 |
| 142 | MP0003632_abnormal_nervous_system | 0.55384022 |
| 143 | MP0002282_abnormal_trachea_morphology | 0.53199617 |
| 144 | MP0002092_abnormal_eye_morphology | 0.52969295 |
| 145 | MP0008995_early_reproductive_senescence | 0.51913494 |
| 146 | MP0000163_abnormal_cartilage_morphology | 0.51806007 |
| 147 | MP0002108_abnormal_muscle_morphology | 0.51117870 |
| 148 | MP0000767_abnormal_smooth_muscle | 0.50307515 |
| 149 | MP0000003_abnormal_adipose_tissue | 0.48439110 |
| 150 | MP0003866_abnormal_defecation | 0.46913453 |
| 151 | MP0003011_delayed_dark_adaptation | 0.45915086 |
| 152 | MP0001542_abnormal_bone_strength | 0.45723697 |
| 153 | MP0002249_abnormal_larynx_morphology | 0.45459749 |
| 154 | MP0000372_irregular_coat_pigmentation | 0.44341616 |
| 155 | MP0008057_abnormal_DNA_replication | 0.43416657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 7.46786326 |
| 2 | Hypoplasia of the fovea (HP:0007750) | 7.46786326 |
| 3 | Abnormality of the fovea (HP:0000493) | 6.25632625 |
| 4 | Focal motor seizures (HP:0011153) | 5.82286259 |
| 5 | Myokymia (HP:0002411) | 5.41681970 |
| 6 | Aplasia/Hypoplasia of the macula (HP:0008059) | 5.13265366 |
| 7 | Difficulty running (HP:0009046) | 4.87146642 |
| 8 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 4.73941527 |
| 9 | Poor eye contact (HP:0000817) | 4.51027370 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 4.37499319 |
| 11 | Focal seizures (HP:0007359) | 4.35459756 |
| 12 | Visual hallucinations (HP:0002367) | 4.09079404 |
| 13 | Impaired social interactions (HP:0000735) | 4.04858794 |
| 14 | Abnormal social behavior (HP:0012433) | 4.04858794 |
| 15 | Optic nerve coloboma (HP:0000588) | 4.03737953 |
| 16 | Hip dysplasia (HP:0001385) | 4.01213438 |
| 17 | Hyperventilation (HP:0002883) | 3.94699355 |
| 18 | Aplasia/Hypoplasia of the lens (HP:0008063) | 3.90424375 |
| 19 | Epileptic encephalopathy (HP:0200134) | 3.87044264 |
| 20 | Broad-based gait (HP:0002136) | 3.59905346 |
| 21 | Postural instability (HP:0002172) | 3.48536566 |
| 22 | Keratitis (HP:0000491) | 3.47598705 |
| 23 | Congenital primary aphakia (HP:0007707) | 3.43646083 |
| 24 | Febrile seizures (HP:0002373) | 3.40597375 |
| 25 | Nephrogenic diabetes insipidus (HP:0009806) | 3.38823027 |
| 26 | Atonic seizures (HP:0010819) | 3.26651891 |
| 27 | Tubulointerstitial nephritis (HP:0001970) | 3.25977546 |
| 28 | Long nose (HP:0003189) | 3.25420964 |
| 29 | Optic nerve hypoplasia (HP:0000609) | 3.24767581 |
| 30 | Papillary thyroid carcinoma (HP:0002895) | 3.19043571 |
| 31 | Progressive cerebellar ataxia (HP:0002073) | 3.16594582 |
| 32 | Absence seizures (HP:0002121) | 3.06759684 |
| 33 | Generalized tonic-clonic seizures (HP:0002069) | 2.97768272 |
| 34 | Thyroiditis (HP:0100646) | 2.90040099 |
| 35 | Anxiety (HP:0000739) | 2.89768628 |
| 36 | Ankle clonus (HP:0011448) | 2.89061900 |
| 37 | Excessive salivation (HP:0003781) | 2.87092653 |
| 38 | Drooling (HP:0002307) | 2.87092653 |
| 39 | Depression (HP:0000716) | 2.85846050 |
| 40 | Amyotrophic lateral sclerosis (HP:0007354) | 2.84166120 |
| 41 | Congenital glaucoma (HP:0001087) | 2.81125433 |
| 42 | Action tremor (HP:0002345) | 2.74143073 |
| 43 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.72802068 |
| 44 | Renal cortical cysts (HP:0000803) | 2.64819149 |
| 45 | Abnormality of the aortic arch (HP:0012303) | 2.61711509 |
| 46 | Truncal ataxia (HP:0002078) | 2.61639558 |
| 47 | Fair hair (HP:0002286) | 2.59483784 |
| 48 | Dialeptic seizures (HP:0011146) | 2.58394496 |
| 49 | Blue irides (HP:0000635) | 2.57275218 |
| 50 | Poor coordination (HP:0002370) | 2.57089021 |
| 51 | Gait ataxia (HP:0002066) | 2.55831345 |
| 52 | Abnormality of the lower motor neuron (HP:0002366) | 2.54331925 |
| 53 | Nephronophthisis (HP:0000090) | 2.54152736 |
| 54 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.50534866 |
| 55 | Mask-like facies (HP:0000298) | 2.50110276 |
| 56 | Pheochromocytoma (HP:0002666) | 2.48015658 |
| 57 | Epileptiform EEG discharges (HP:0011182) | 2.46781486 |
| 58 | Hip contracture (HP:0003273) | 2.45892047 |
| 59 | Spastic gait (HP:0002064) | 2.45799701 |
| 60 | Prolonged QT interval (HP:0001657) | 2.45208820 |
| 61 | True hermaphroditism (HP:0010459) | 2.44280490 |
| 62 | Mutism (HP:0002300) | 2.43861783 |
| 63 | Protruding tongue (HP:0010808) | 2.43058064 |
| 64 | Scanning speech (HP:0002168) | 2.42430936 |
| 65 | EEG with generalized epileptiform discharges (HP:0011198) | 2.41177674 |
| 66 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.40203484 |
| 67 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.40203484 |
| 68 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.37290835 |
| 69 | Agitation (HP:0000713) | 2.37136428 |
| 70 | Severe combined immunodeficiency (HP:0004430) | 2.37016079 |
| 71 | Abnormal eating behavior (HP:0100738) | 2.35844774 |
| 72 | Generalized hypopigmentation of hair (HP:0011358) | 2.35742201 |
| 73 | Tetraplegia (HP:0002445) | 2.35655432 |
| 74 | Abnormality of eosinophils (HP:0001879) | 2.35045218 |
| 75 | Large eyes (HP:0001090) | 2.28340232 |
| 76 | Absent speech (HP:0001344) | 2.27354008 |
| 77 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.27335267 |
| 78 | Absent/shortened dynein arms (HP:0200106) | 2.27335267 |
| 79 | Abnormality of the renal cortex (HP:0011035) | 2.23661359 |
| 80 | Impaired smooth pursuit (HP:0007772) | 2.22156706 |
| 81 | Abnormal EKG (HP:0003115) | 2.21657689 |
| 82 | Prominent supraorbital ridges (HP:0000336) | 2.21213510 |
| 83 | Hypsarrhythmia (HP:0002521) | 2.20417612 |
| 84 | Pancreatic fibrosis (HP:0100732) | 2.19813284 |
| 85 | Bradykinesia (HP:0002067) | 2.19233544 |
| 86 | Abnormal protein glycosylation (HP:0012346) | 2.17073426 |
| 87 | Abnormal glycosylation (HP:0012345) | 2.17073426 |
| 88 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.17073426 |
| 89 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.17073426 |
| 90 | Genital tract atresia (HP:0001827) | 2.17001704 |
| 91 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.15678551 |
| 92 | Abnormality of the renal medulla (HP:0100957) | 2.14151524 |
| 93 | Papilledema (HP:0001085) | 2.14107853 |
| 94 | Dysmetria (HP:0001310) | 2.13648367 |
| 95 | Stereotypic behavior (HP:0000733) | 2.13529823 |
| 96 | Menstrual irregularities (HP:0000858) | 2.12325023 |
| 97 | Vaginal atresia (HP:0000148) | 2.09398325 |
| 98 | Insomnia (HP:0100785) | 2.09169630 |
| 99 | Pachygyria (HP:0001302) | 2.09155470 |
| 100 | Dysdiadochokinesis (HP:0002075) | 2.08210805 |
| 101 | Thyroid carcinoma (HP:0002890) | 2.07588344 |
| 102 | Pancreatic cysts (HP:0001737) | 2.07339693 |
| 103 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.07061603 |
| 104 | Inability to walk (HP:0002540) | 2.06885708 |
| 105 | Polyphagia (HP:0002591) | 2.06213396 |
| 106 | Torticollis (HP:0000473) | 2.05414903 |
| 107 | Lissencephaly (HP:0001339) | 2.04775417 |
| 108 | Rigidity (HP:0002063) | 2.02604036 |
| 109 | Abnormality of salivation (HP:0100755) | 2.01560737 |
| 110 | Neuroendocrine neoplasm (HP:0100634) | 2.01195562 |
| 111 | Psychosis (HP:0000709) | 2.00734285 |
| 112 | Specific learning disability (HP:0001328) | 2.00260114 |
| 113 | Hypoventilation (HP:0002791) | 1.99117967 |
| 114 | Corneal dystrophy (HP:0001131) | 1.98850705 |
| 115 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.98632665 |
| 116 | Autism (HP:0000717) | 1.97087294 |
| 117 | Dyskinesia (HP:0100660) | 1.96495869 |
| 118 | Neurofibrillary tangles (HP:0002185) | 1.96133630 |
| 119 | Rhinitis (HP:0012384) | 1.95727197 |
| 120 | Urinary urgency (HP:0000012) | 1.94759077 |
| 121 | Cerebral inclusion bodies (HP:0100314) | 1.93537032 |
| 122 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.92935077 |
| 123 | Tubulointerstitial abnormality (HP:0001969) | 1.92885921 |
| 124 | Status epilepticus (HP:0002133) | 1.92682739 |
| 125 | Progressive inability to walk (HP:0002505) | 1.91926128 |
| 126 | Hemiplegia (HP:0002301) | 1.91699433 |
| 127 | Athetosis (HP:0002305) | 1.91527409 |
| 128 | Decreased circulating renin level (HP:0003351) | 1.91271490 |
| 129 | Failure to thrive in infancy (HP:0001531) | 1.89551564 |
| 130 | Intention tremor (HP:0002080) | 1.89481508 |
| 131 | Scrotal hypoplasia (HP:0000046) | 1.88480805 |
| 132 | Lower limb muscle weakness (HP:0007340) | 1.87526981 |
| 133 | Macroorchidism (HP:0000053) | 1.87479915 |
| 134 | Macular degeneration (HP:0000608) | 1.86720949 |
| 135 | Abnormal hair whorl (HP:0010721) | 1.86023188 |
| 136 | Abnormal ciliary motility (HP:0012262) | 1.84474768 |
| 137 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.84412797 |
| 138 | Tented upper lip vermilion (HP:0010804) | 1.84284374 |
| 139 | Attenuation of retinal blood vessels (HP:0007843) | 1.84131635 |
| 140 | Spinal canal stenosis (HP:0003416) | 1.83474440 |
| 141 | Postaxial foot polydactyly (HP:0001830) | 1.82726458 |
| 142 | Gaze-evoked nystagmus (HP:0000640) | 1.82211369 |
| 143 | Progressive microcephaly (HP:0000253) | 1.81573506 |
| 144 | Occipital encephalocele (HP:0002085) | 1.81565204 |
| 145 | Recurrent sinusitis (HP:0011108) | 1.80743326 |
| 146 | Decreased central vision (HP:0007663) | 1.80387261 |
| 147 | Growth hormone deficiency (HP:0000824) | 1.79446727 |
| 148 | Short foot (HP:0001773) | 1.78986373 |
| 149 | Astigmatism (HP:0000483) | 1.77329578 |
| 150 | Focal dystonia (HP:0004373) | 1.77280008 |
| 151 | Exotropia (HP:0000577) | 1.76800789 |
| 152 | Bronchomalacia (HP:0002780) | 1.76696614 |
| 153 | Spastic tetraplegia (HP:0002510) | 1.75943268 |
| 154 | Broad foot (HP:0001769) | 1.75881214 |
| 155 | Growth hormone excess (HP:0000845) | 1.75530286 |
| 156 | Gait imbalance (HP:0002141) | 1.75423383 |
| 157 | Congenital hepatic fibrosis (HP:0002612) | 1.75410580 |
| 158 | Postaxial hand polydactyly (HP:0001162) | 1.75213112 |
| 159 | Medulloblastoma (HP:0002885) | 1.74508777 |
| 160 | Widely spaced teeth (HP:0000687) | 1.73489791 |
| 161 | Megalencephaly (HP:0001355) | 1.72591432 |
| 162 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.72045000 |
| 163 | Type I transferrin isoform profile (HP:0003642) | 1.71227969 |
| 164 | Elfin facies (HP:0004428) | 1.71141437 |
| 165 | Chronic hepatic failure (HP:0100626) | 1.70858636 |
| 166 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.70196474 |
| 167 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.70093898 |
| 168 | Autoamputation (HP:0001218) | 1.69562300 |
| 169 | Ketoacidosis (HP:0001993) | 1.67576409 |
| 170 | Open mouth (HP:0000194) | 1.67453006 |
| 171 | Polar cataract (HP:0010696) | 1.67441379 |
| 172 | Medial flaring of the eyebrow (HP:0010747) | 1.67326621 |
| 173 | Amblyopia (HP:0000646) | 1.67078603 |
| 174 | Abnormality of secondary sexual hair (HP:0009888) | 1.66741704 |
| 175 | Abnormality of the axillary hair (HP:0100134) | 1.66741704 |
| 176 | Palpebral edema (HP:0100540) | 1.66463197 |
| 177 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.65864140 |
| 178 | Hypoplasia of the brainstem (HP:0002365) | 1.65864140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.21804491 |
| 2 | EPHA4 | 3.91739227 |
| 3 | TAOK3 | 3.60994044 |
| 4 | MAP3K4 | 2.91752882 |
| 5 | BCR | 2.88136979 |
| 6 | INSRR | 2.74010286 |
| 7 | MARK1 | 2.69070612 |
| 8 | CASK | 2.59237066 |
| 9 | MAP3K9 | 2.51371323 |
| 10 | EPHA3 | 2.41480602 |
| 11 | MAP2K7 | 2.34942613 |
| 12 | FRK | 2.32729873 |
| 13 | MINK1 | 2.22025329 |
| 14 | BCKDK | 2.18048738 |
| 15 | PRKD3 | 2.02644297 |
| 16 | NTRK2 | 2.00217589 |
| 17 | CAMKK2 | 1.82318892 |
| 18 | LMTK2 | 1.80739329 |
| 19 | PIM2 | 1.77333880 |
| 20 | MAP3K12 | 1.74990011 |
| 21 | DAPK2 | 1.73405443 |
| 22 | TESK2 | 1.73172786 |
| 23 | PAK6 | 1.72710498 |
| 24 | BRD4 | 1.70886266 |
| 25 | MAP4K2 | 1.68595746 |
| 26 | SRPK1 | 1.67352792 |
| 27 | CAMKK1 | 1.63128668 |
| 28 | MAP2K4 | 1.62961445 |
| 29 | MAPK13 | 1.60121027 |
| 30 | EPHB1 | 1.55781397 |
| 31 | CSNK1A1L | 1.49982719 |
| 32 | SGK223 | 1.49693205 |
| 33 | SGK494 | 1.49693205 |
| 34 | UHMK1 | 1.47602399 |
| 35 | CSNK1G3 | 1.39495531 |
| 36 | LATS1 | 1.38448128 |
| 37 | GRK1 | 1.38303857 |
| 38 | SGK2 | 1.37093168 |
| 39 | PHKG2 | 1.35479284 |
| 40 | PHKG1 | 1.35479284 |
| 41 | CDK5 | 1.34520544 |
| 42 | RIPK4 | 1.32465386 |
| 43 | SIK2 | 1.32158156 |
| 44 | TNIK | 1.31913591 |
| 45 | TRIM28 | 1.31507887 |
| 46 | CDK3 | 1.23239405 |
| 47 | NTRK1 | 1.22687141 |
| 48 | KSR1 | 1.16694967 |
| 49 | PRKCH | 1.15295418 |
| 50 | CDK12 | 1.14255106 |
| 51 | MAPKAPK5 | 1.12609429 |
| 52 | SGK3 | 1.11785870 |
| 53 | FES | 1.09213671 |
| 54 | KSR2 | 1.03646390 |
| 55 | PRKCG | 1.03315785 |
| 56 | CAMK1G | 1.03178429 |
| 57 | DAPK1 | 1.01952346 |
| 58 | PAK3 | 1.00245547 |
| 59 | PLK2 | 0.98164693 |
| 60 | ERBB3 | 0.97316964 |
| 61 | RAF1 | 0.95460642 |
| 62 | CAMK1 | 0.93258394 |
| 63 | CSNK1G1 | 0.91558508 |
| 64 | PINK1 | 0.91167976 |
| 65 | CAMK2A | 0.90824176 |
| 66 | DYRK1B | 0.89869198 |
| 67 | NEK9 | 0.89474940 |
| 68 | TESK1 | 0.89235855 |
| 69 | CDK19 | 0.88491432 |
| 70 | AKT3 | 0.88079043 |
| 71 | DYRK1A | 0.86399484 |
| 72 | WNK1 | 0.83689036 |
| 73 | PTK2B | 0.83186230 |
| 74 | GRK5 | 0.82847382 |
| 75 | MAP3K5 | 0.82509380 |
| 76 | PIK3CA | 0.81229665 |
| 77 | ICK | 0.80977098 |
| 78 | MAP3K13 | 0.80665713 |
| 79 | MARK2 | 0.79032881 |
| 80 | STK38 | 0.78968446 |
| 81 | GRK6 | 0.78784085 |
| 82 | CAMK2B | 0.78663579 |
| 83 | MAPK7 | 0.78024010 |
| 84 | STK38L | 0.76037781 |
| 85 | ADRBK2 | 0.74724095 |
| 86 | MAP3K2 | 0.73764306 |
| 87 | RPS6KA4 | 0.73599196 |
| 88 | ERN1 | 0.72256812 |
| 89 | PRKCE | 0.71613138 |
| 90 | PRPF4B | 0.70328617 |
| 91 | CAMK4 | 0.69557720 |
| 92 | SIK3 | 0.69122365 |
| 93 | MAP3K6 | 0.67474744 |
| 94 | SGK1 | 0.65315617 |
| 95 | RET | 0.63920122 |
| 96 | BMPR1B | 0.62326376 |
| 97 | LIMK1 | 0.61661643 |
| 98 | CDK14 | 0.61129799 |
| 99 | MAPK15 | 0.60512380 |
| 100 | CDK18 | 0.59423146 |
| 101 | WNK3 | 0.59305062 |
| 102 | CSNK1G2 | 0.58142440 |
| 103 | FER | 0.58121827 |
| 104 | RPS6KA2 | 0.58067837 |
| 105 | CDK15 | 0.56197011 |
| 106 | PRKD2 | 0.55586050 |
| 107 | RPS6KA3 | 0.54212498 |
| 108 | DYRK2 | 0.53767772 |
| 109 | PNCK | 0.52499365 |
| 110 | NEK6 | 0.49949139 |
| 111 | FYN | 0.49727887 |
| 112 | JAK1 | 0.49335202 |
| 113 | JAK2 | 0.49212256 |
| 114 | MAPK11 | 0.48877351 |
| 115 | MAP3K7 | 0.48513696 |
| 116 | PRKCZ | 0.48101966 |
| 117 | PRKAA1 | 0.47643220 |
| 118 | BMPR2 | 0.47169520 |
| 119 | OXSR1 | 0.46075694 |
| 120 | CSNK1D | 0.45893196 |
| 121 | MAP3K11 | 0.45727351 |
| 122 | RPS6KA5 | 0.45052061 |
| 123 | STK11 | 0.44073846 |
| 124 | WNK4 | 0.43612145 |
| 125 | PRKG1 | 0.43524790 |
| 126 | CDK6 | 0.42550691 |
| 127 | CDK11A | 0.42279343 |
| 128 | PDGFRA | 0.41787236 |
| 129 | CAMK2G | 0.41437110 |
| 130 | ADRBK1 | 0.40909578 |
| 131 | CCNB1 | 0.40845563 |
| 132 | PDK1 | 0.40601880 |
| 133 | CAMK2D | 0.40552741 |
| 134 | CAMK1D | 0.40516086 |
| 135 | IRAK2 | 0.40416932 |
| 136 | LCK | 0.39917023 |
| 137 | PRKCA | 0.39776703 |
| 138 | CDC42BPA | 0.38089780 |
| 139 | PRKACA | 0.37426181 |
| 140 | SCYL2 | 0.36945847 |
| 141 | IKBKE | 0.36830282 |
| 142 | SRC | 0.36701219 |
| 143 | MAP2K1 | 0.36509976 |
| 144 | SIK1 | 0.36498512 |
| 145 | PRKD1 | 0.35900198 |
| 146 | HIPK2 | 0.35748199 |
| 147 | PRKCB | 0.35572440 |
| 148 | PIK3CG | 0.34985137 |
| 149 | CSNK1A1 | 0.34976495 |
| 150 | TYK2 | 0.34945851 |
| 151 | TXK | 0.34142133 |
| 152 | ZAP70 | 0.33375228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.19722274 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.78800002 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.62151807 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.56090045 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.53429044 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.44610060 |
| 7 | Insulin secretion_Homo sapiens_hsa04911 | 2.42876982 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.42240593 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.36709029 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.32695496 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.30250053 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.28830418 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.01921331 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.99946383 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.97369834 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.95408805 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.90030742 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.84606427 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.79307638 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.79288380 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.79070428 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.69884228 |
| 23 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.69134478 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.61018646 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58189211 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50171039 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.45978559 |
| 28 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.44841603 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.43966820 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.38261973 |
| 31 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.37551823 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.36538412 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.32875672 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29644358 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.27027350 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.26730804 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22833446 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.22577528 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22063588 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20673119 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.18121054 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.16948818 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16120276 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.09803298 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.07151274 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.06562763 |
| 47 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.03660669 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.02312963 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.01644661 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01472558 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00313205 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97962441 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94808148 |
| 54 | Peroxisome_Homo sapiens_hsa04146 | 0.94124404 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93593601 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92897086 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.90849672 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 0.90447291 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 0.89414785 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86938123 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.84899484 |
| 62 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.84004369 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80423797 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.79249141 |
| 65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78271819 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.78095507 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78009955 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77514215 |
| 69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76290949 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.76277297 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75517721 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73091613 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72837972 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72269858 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72200183 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.71562035 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70682692 |
| 78 | Measles_Homo sapiens_hsa05162 | 0.70458898 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67540814 |
| 80 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67259252 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66517665 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66429459 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65938968 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.64595835 |
| 85 | Phototransduction_Homo sapiens_hsa04744 | 0.61863391 |
| 86 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.60092260 |
| 87 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59911543 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59034818 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59001899 |
| 90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58789503 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58453521 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58322383 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58010502 |
| 94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57897849 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57792422 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57201843 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.56659972 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55326665 |
| 99 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.54967947 |
| 100 | Tuberculosis_Homo sapiens_hsa05152 | 0.54715446 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54646652 |
| 102 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54058641 |
| 103 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54037374 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53621037 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53204654 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52583448 |
| 107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50914714 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50427610 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50381158 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50205146 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49895675 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49249258 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48189040 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48068558 |
| 115 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47080875 |
| 116 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.46729321 |
| 117 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.45952679 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.45356683 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45185280 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44728838 |
| 121 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44618736 |
| 122 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44080079 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43670344 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43064043 |
| 125 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.42760754 |
| 126 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42424894 |
| 127 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42173918 |
| 128 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41909867 |
| 129 | ABC transporters_Homo sapiens_hsa02010 | 0.40966001 |
| 130 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40458039 |
| 131 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40387046 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38581293 |
| 133 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37350473 |
| 134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36033617 |
| 135 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35971677 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.35137352 |
| 137 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33285569 |
| 138 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.32688977 |
| 139 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29396555 |
| 140 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27336463 |
| 141 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25878059 |
| 142 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.25739385 |
| 143 | Alcoholism_Homo sapiens_hsa05034 | 0.24654343 |
| 144 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.24325270 |
| 145 | Insulin resistance_Homo sapiens_hsa04931 | 0.23363538 |

